Trial Profile
A retrospective study evaluating effect of substituting calcineurin inhibitors by sirolimus on cardiac allograft vasculopathy and cardiac events in heart transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Calcineurin inhibitors
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 24 Apr 2017 New trial record
- 08 Apr 2017 Results presented at the 37th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation